Company Overview
Snapshot
Founded in June 2009 by Giora Dishon, Moshe Finarov, Amir Noy, and Misha Matusovsky, DR Utilight operates with 11–50 employees. The company has raised over $10.69 million across four funding rounds from four investors.
Business overview
DR Utilight specializes in developing Pattern Transfer Printing (PTP), an advanced printing technology designed for the photovoltaic (PV) metallization process of c-Si solar cells. This technology aims to enhance solar cell efficiency while simultaneously reducing the silver content on the cell and lowering overall PV manufacturing costs. The company serves the energy tech and industrial technologies sectors, with a focus on renewable energy systems, particularly solar, and has established strategic partnerships with solar cell manufacturers in key markets such as China and Taiwan.
Strategic signal
In December 2018, DR Utilight was highlighted for its efforts to energize the Gaza border economy through its solar technology. This signals the company's potential for broader social and economic impact beyond pure technological advancement, suggesting a strategic focus on regional development and sustainable energy solutions that could attract impact-focused investors and partners.
Log in to access full profile ›Company Intelligence Q&A
- What is DR Utilight's core technology?
- DR Utilight's core technology is Pattern Transfer Printing (PTP), a printing method designed for the photovoltaic (PV) metallization process of c-Si solar cells. This technology aims to increase solar cell efficiency and reduce silver usage and manufacturing costs.
- When was DR Utilight founded and by whom?
- DR Utilight was founded in June 2009 by Giora Dishon, Moshe Finarov, Amir Noy, and Misha Matusovsky.
- Which markets does DR Utilight target?
- DR Utilight targets geomarkets including China, Taiwan, Asia, and Europe, focusing on strategic partnerships with solar cell manufacturers in these regions.
- What is the total capital raised by DR Utilight?
- DR Utilight has raised over $10.69 million across 4 funding rounds.